


EliTest Health operates as a specialized men's health and medical weight loss clinic in Rockford, Illinois, under the clinical direction of Nick McKeown, a board-certified Physician Assistant. The practice concentrates on three interconnected areas of male wellness: testosterone optimization, medical weight loss through GLP-1 receptor agonist therapy, and erectile dysfunction treatment. McKeown's clinical model integrates hormone assessment with metabolic health interventions, recognizing that testosterone deficiency, excess adiposity, and sexual dysfunction frequently coexist and require coordinated treatment strategies rather than isolated symptom management.
The clinic's medical weight loss protocols center on two FDA-approved GLP-1 medications: semaglutide and tirzepatide. Semaglutide, a glucagon-like peptide-1 receptor agonist, works by enhancing insulin secretion, suppressing glucagon release, and slowing gastric emptying to reduce appetite and caloric intake. Tirzepatide functions as a dual GIP/GLP-1 receptor agonist, activating both glucose-dependent insulinotropic polypeptide and GLP-1 pathways for enhanced glycemic control and weight reduction. EliTest Health prescribes these medications as part of structured programs that include baseline metabolic panels, body composition analysis, and ongoing dosage titration based on individual tolerance and response. Patients typically begin with lower doses that escalate over 16-20 weeks to therapeutic levels, with McKeown monitoring for common side effects including nausea, constipation, and changes in heart rate. The clinic's testosterone replacement protocols address hypogonadism through multiple delivery methods, with treatment plans designed around patient preference, lifestyle factors, and specific symptom profiles including low libido, fatigue, reduced muscle mass, and mood changes.
Nick McKeown brings clinical experience in hormone modulation and metabolic medicine to his role as lead provider at EliTest Health. As a Physician Assistant-Certified, McKeown conducts comprehensive intake evaluations that include detailed symptom inventories, physical examinations, and laboratory workups measuring total testosterone, free testosterone, estradiol, thyroid function, lipid panels, hemoglobin A1c, and other relevant biomarkers. His approach to erectile dysfunction treatment considers both hormonal and vascular factors, often identifying testosterone deficiency or metabolic syndrome as underlying contributors. The clinic's treatment algorithms for ED incorporate phosphodiesterase-5 inhibitors when appropriate, but prioritize addressing root hormonal imbalances and cardiovascular risk factors that pharmaceutical interventions alone cannot resolve. McKeown's patient consultations typically explore lifestyle factors including sleep quality, stress levels, exercise patterns, and nutritional habits that influence hormonal balance and treatment outcomes.
Patients at EliTest Health in Rockford begin with an initial consultation that can be conducted either in-person at the clinic or via telehealth platform, depending on individual preference and geographic convenience. The intake process includes a clinical interview covering medical history, current symptoms, previous treatments, and health goals, followed by laboratory requisition for baseline hormone and metabolic testing. Once results return, McKeown reviews findings with patients and presents treatment options with specific protocols, expected timelines, monitoring requirements, and potential side effects. For medical weight loss patients starting semaglutide or tirzepatide, the clinic provides injection training, supplies, and a titration schedule with planned follow-up intervals at four, eight, and twelve weeks initially, then quarterly for maintenance. Testosterone replacement patients receive similar structured monitoring with periodic labs to assess treatment response and adjust dosing. The clinic schedules follow-up visits as telehealth appointments when appropriate, allowing patients across northern Illinois to access ongoing care without repeated travel to Rockford.
EliTest Health's hybrid care model combining in-person and telehealth services addresses a practical barrier many men face when seeking hormone and weight management treatment: time constraints and scheduling inflexibility. The clinic's telehealth infrastructure enables patients to complete follow-up consultations, review laboratory results, discuss dosage adjustments, and address concerns without office visits, while maintaining the option for in-person evaluation when physical examination or procedural interventions are indicated. This accessibility has contributed to the clinic's patient satisfaction metrics, reflected in its 5.0-star rating across 18 Google reviews. McKeown's practice philosophy emphasizes patient education throughout treatment, providing clear explanations of how testosterone, GLP-1 medications, and related interventions work at a physiological level, what realistic outcomes look like over specific timeframes, and how lifestyle modifications can enhance therapeutic results. The clinic serves men throughout the Rockford metropolitan area and surrounding communities in northern Illinois who are seeking evidence-based approaches to hormone optimization, sustainable weight loss, and sexual health restoration.
Nick McKeown· PAC
Nick McKeown, PAC
Provider
Nick is a compassionate and knowledgeable provider who takes the time to listen to patients and create personalized care plans.
Testosterone Replacement Therapy
Rediscover your strength, confidence, and vitality. Low testosterone (Low T) can quietly affect nearly every aspect of a man’s life from energy and performance to mood and motivation.
Medical Weight Loss
Patients have transformed their lives through EliTest Health’s customized medical weight loss programs.
Erectile Dysfunction
Our personalized ED treatments have helped men restore performance and intimacy without embarrassment or hassle.
MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.


